DBV Technologies

DBVT Lead: NDA Submitted 8 Biotech Distilled articles ↓

Most recent annual filing: 2026-03-15

Catalyst timeline

Viaskin Peanut Toddlers 1-3yo BLA2H 2026Viaskin Peanut Toddlers 1-3yo BLA, 2H 2026, material
Toddler BLA ages 1-3 filing2H 2026Toddler BLA ages 1-3 filing, 2H 2026, material

Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.

Pipeline (2 active programs)

Viaskin Peanut

DBV712

Protein

Peanut Allergy NDA Submitted topical NCT01675882

Viaskin Milk

VIASKIN milk patch · DBV135

Protein

Cow's Milk Allergy Phase 1 topical NCT02223182

Technology platforms

Viaskin

Epicutaneous immunotherapy (EPIT) patch delivery platform; designed to re-educate the immune system via skin-based antigen delivery; focus area: food allergies and other immunological diseases including peanut allergy and cow's milk allergy

Discontinued (1)

Viaskin Milk — Eosinophilic Esophagitis

Biotech Distilled coverage (8)

2026-09-30 UPDATE: DBV Technologies (DBVT) - The BLA Is In. The Clock Is Running. 🔒 Paid
2026-08-07 UPDATE: DBV Technologies (DBVT) - Who Bought the $50M 🔒 Paid
2026-07-31 UPDATE: DBV Technologies (DBVT) - They Used the ATM. Fast. 🔒 Paid
2026-07-17 UPDATE: DBV Technologies (DBVT) - The ATM Refills, One Day After the Warning Letter 🔒 Paid
2026-07-16 UPDATE: DBV Technologies (DBVT) - The Warning Letter Buried in the 10-Q
2026-06-29 UPDATE: DBV Technologies (DBVT) - The BLA Slips a Quarter
2026-03-28 UPDATE: DBV Technologies (DBVT) - FDA Hits Fast Forward 🔒 Paid
2025-12-22 DBV Technologies (DBVT): Scientific Due Diligence 🔒 Paid

Articles open on Substack. Some are subscriber-only; those marked ★ Distilled Pro are for Distilled Pro members.